admin

Clopidogrel may reduce inflammation and thrombogenicity in HIV

By Darlene Dobkowski According to a study published in Science Advances, the increased risk of cardiovascular disease in HIV patients was associated with greater thrombogenicity that interacted with markers of immune and inflammatory activation, which improved with clopidogrel compared to aspirin or placebo. “Treatment with clopidogrel may reduce the thrombogenicity of

Clopidogrel may reduce inflammation and thrombogenicity in HIV. Read More »

UNAIDS and UNDP are calling in 48* countries and territories to remove all HIV-related travel restrictions.

By: Unaids.org Press Release Recent data show that in 2019 some 48* countries and territories still maintain restrictions requiring mandatory HIV testing and declaration of serological status as part of the requirements for entry, residence, work and/or study permits GENEVA, 27 June 2019—UNAIDS and the Programme

UNAIDS and UNDP are calling on 48* countries and territories to remove all HIV-related travel restrictions. Read More »

Gay men assume that attractive people do not have HIV

By: ENEWSPAPER – https://www.enewspaper.mx/los-hombres-gay-asumen-que-las-personas-atractivas-no-tienen-vih/ A new study found that gay and bisexual men are more likely to believe that men they find physically attractive are less likely to have an STI (Sexually Transmitted Infection). Researchers at the University of Maryland surveyed 200 gay and bisexual men across the US, showed them clips of different men, and then asked them to rank them based on

Gay men assume attractive people don't have HIV. Read More »

Patients with HIV are less likely to be included on the waiting list for a kidney transplant

By: Melissa J. Webb – https://www.healio.com/nephrology/transplantation/news/online/%7B88461176-c1d5-4153-aaf3-879af5c2137d%7D/patients-with-hiv-less-likely-to-be-waitlisted-for-kidney-transplant BOSTON: According to research presented at the American Transplant Congress, patients with HIV were less likely to be placed on the kidney transplant waiting list than patients without HIV. They also experienced longer wait times from evaluation to listing. “Patients with

Patients with HIV are less likely to be included on the waiting list for a kidney transplant. Read More »

Rates of invasive cervical cancer are high among women with HIV in South Africa and Latin America

By Kate Anderton, B.Sc. – https://www.news-medical.net/news/20190619/Invasive-cervical-cancer-rates-are-high-among-women-with-HIV-in-South-Africa-Latin-America.aspx A new study in the International Journal of Cancer indicates that invasive cervical cancer (ICC) rates are particularly high among women living with HIV in South Africa and Latin America. For the study, researchers compared ICC rates in 45 countries across Europe, South Africa, and Latin America.

Rates of invasive cervical cancer are high among women with HIV in South Africa and Latin America. Read More »

Participation of civil society in universal health coverage.

By: UNAIDS – https://www.unaids.org/en/resources/presscentre/featurestories/2019/june/20190626_cs-uhc Achieving universal health coverage in a country is an ambitious but transformative goal. Communities are essential to the AIDS response and will be essential to the successful rollout of universal health coverage (UHC). When national governments establish a committee to coordinate universal health coverage, it is

Civil society participation in universal health coverage. Read More »

LGBT rights in Latin America: the path of political minorities

By: Jorge Galindo – https://elpais.com/internacional/2019/06/21/america/1561126403_693676.html We cannot underestimate the importance and potential of counter-majoritarian institutions for the advancement of LGBT rights in Latin America. Unequal. That is the appropriate adjective to describe the situation of LGBT rights in Latin America and the Caribbean. The part of daily life that depends on the

LGBT Rights in Latin America: The Path of Political Minorities Read More »

Cases of hair loss in African American women reported after switching to the new tenofovir formulation

By: Michael Carter – http://www.aidsmap.com/page/3536944/ According to doctors reporting at the Infectious Diseases Open Forum, hair loss (alopecia) occurred in six African American women living with HIV after switching to the new formulation of tenofovir. The clinical trials that led to the approval of tenofovir alafenamide in 2015 did not identify hair loss as a side effect.

Cases of hair loss in African American women reported after switching to the new tenofovir formulation Read More »

Argentina launches a new HIV treatment: what is it?

By: MDZ WORLD – https://www.mdzol.com/mundo/argentina-desarrolla-nuevo-tratamiento-para-el-vih-de-que-se-trata-20190626-33782.html Richmond Laboratories announced the launch of ZEVUVIR, a drug whose objective is to delay the progression of the virus in patients. Richmond Laboratories, one of the leading suppliers of oncology and HIV-related medications in Argentina, announced on Monday the launch of ZEVUVIR, a drug that seeks to delay

Argentina launches a new HIV treatment: What is it? Read More »